Epidemiology and prevention of cardiac failure: Framingham Study insights.
about
Management of chronic heart failure in the community: role of a hospital based open access heart failure service.Ischaemic heart failure: is prevention in sight?Results of clinical trials with diuretics in heart failure.Managing anemia in patients with chronic heart failure: what do we know?Alcohol consumption and risk of death in male physicians with heart failureIncidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom.Predictors of heart failure in patients with stable coronary artery disease: a PEACE study.Clinical and echocardiographic findings of newly diagnosed acute decompensated heart failure in elderly patientsClinical evidence review: best practice heart failure."Apparent" heart failure: a syndrome caused by renal artery stenoses.Survival differences between heart failure in general practices and in hospitals.Anaemia is associated with higher mortality among patients with heart failure with preserved systolic functionAngiotensin converting enzyme inhibitors for hypertension and heart failure?Advanced heart failure and transplantation in women.A review of homocysteine and heart failure.Imaging of myocardial dyssynchrony in congestive heart failure.Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.Beta-blockers to prevent symptomatic heart failure in patients with stage A and B heart failure.Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome.Incident heart failure prediction in the elderly: the health ABC heart failure score.Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland.Impact of Cardiorenal Anemia Syndrome on Short- and Long-Term Clinical Outcomes in Patients Hospitalized with Heart Failure.Congestive heart failure in elderly patients. The treatment goal is improved quality, not quantity, of life.Losartan attenuates phospholipase C isozyme gene expression in hypertrophied hearts due to volume overload.Association between anemia, clinical features and outcome in patients hospitalized for acute heart failure syndromes.American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.Risk management and outcomes of adverse events to pioglitazone in primary care in the UK: an observational study.Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.Spironolactone improves diastolic function in the elderly.Anemia and cost in Medicare patients with congestive heart failure.Resting heart rate and incident heart failure in apparently healthy men and women in the EPIC-Norfolk study
P2860
Q30482680-B92B648D-B802-4D33-81BC-478447A166CDQ33613101-DF2BD3E0-B412-4110-A5E1-0F7B3A135DF2Q33614258-2C2D6A24-81A8-4464-8F6A-256E3FBB381DQ33797640-A93DB2F8-F14C-444F-84C9-50EDC1E678D2Q34175275-03A88721-7A5D-47A4-9BF7-A6AC8706EFA2Q34395504-AF918460-6603-4184-95F8-0972451A56A5Q34437117-95B58AB7-AF23-45AE-8092-D18035F1396BQ34474630-72B19E7D-BDEE-444A-B6D3-1E6D23A9255BQ34675426-FE0E4A60-B738-4E34-AB01-F4C7DEC17BC5Q35374966-D3CE6FB4-CA61-44B1-82BA-66BF02BEDC09Q35574257-1B266747-F94A-4E45-A201-B53A954041ACQ35770879-3F20FC16-529E-439F-9374-E4F7E2668CC7Q35990307-5AC18D54-46FD-48F7-9376-FD25DFF390E8Q36112954-3D473D1F-D91F-4704-9AA5-06D05213AB3BQ36407790-E5071887-6319-4F46-B0F7-BB93C2A2CD37Q36666465-6EC84C98-C89B-4690-A6E0-A10B707E2FC2Q36682368-38B24F42-5887-4F58-96F2-F9A93089EA19Q36830290-27ECC551-683D-4317-B393-C38875360382Q36839088-435091DF-A875-4AFC-9AE9-83861907EB77Q37032846-14C1C97C-8D11-49A1-A14B-A1077C213BA1Q37356725-B0E8EDA3-3605-4F20-81CC-0610900661B4Q38805331-BEFF4B3E-2139-4852-9BA7-EDCE5053AB62Q41073023-57924E37-3146-41A6-A16E-9D53511CC06CQ41615510-1829F101-BCE8-4E65-8D5B-3411055451D3Q41974516-B9076C82-18AB-4A3F-9985-1F3A3160271DQ43843290-E8B5E951-F9F2-406B-ABD3-FD57531749D7Q44282689-A32E1FDC-9407-4DAA-938D-71BAF580977AQ46065488-AD294196-0BA3-497C-99D0-D37AA2294A73Q46549044-A4FCEB86-C7C4-491C-A895-B6E15C797224Q46793750-039D65EA-6402-4DB0-BAFC-16D044C20389Q51773516-1B61C2E8-AFC1-4088-AF13-015760203535Q57202637-49F4E41F-8175-41D6-B95A-E2EF9EB38AD0
P2860
Epidemiology and prevention of cardiac failure: Framingham Study insights.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Epidemiology and prevention of cardiac failure: Framingham Study insights.
@en
Epidemiology and prevention of cardiac failure: Framingham Study insights.
@nl
type
label
Epidemiology and prevention of cardiac failure: Framingham Study insights.
@en
Epidemiology and prevention of cardiac failure: Framingham Study insights.
@nl
prefLabel
Epidemiology and prevention of cardiac failure: Framingham Study insights.
@en
Epidemiology and prevention of cardiac failure: Framingham Study insights.
@nl
P356
P1476
Epidemiology and prevention of cardiac failure: Framingham Study insights.
@en
P2093
P356
10.1093/EURHEARTJ/8.SUPPL_F.23
P478
P577
1987-09-01T00:00:00Z